A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronate-Reference-Cited by-同舟云学术

A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronate

Published:2016 Issue: Volume:6 Page:20-23
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Sørensen Anders Lindholm,Kallenbach Klaus,Hasselbalch Hans Carl

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference13 articles.

1. Novel prospects of statins as therapeutic agents in cancer;Pisanti;Pharmacol. Res.,2014

2. The mevalonate pathway as a therapeutic target in the pH-negative chronic myeloproliferative disorders;Hasselbalch;Curr. Drug Targets,2007

3. MPNs as inflammatory diseases: the evidence, consequences, and perspectives;Hasselbalch;Mediat. Inflamm.,2015

4. Pleiotropic effects of statins;Liao;Annu Rev. Pharmacol. Toxicol.,2005

5. JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth;Griner;Br. J. Haematol.,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia;Cancer Medicine;2023-09

2. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms;Cancers;2023-08-29

3. Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study;Blood Advances;2023-07-13

4. New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms;HemaSphere;2021-11-18

5. Beneficial effect of ACE inhibitors on kidney function in polycythemia vera;Wiener klinische Wochenschrift;2021-02-08